Suppr超能文献

常见可变免疫缺陷中的T细胞异常。

T-cell abnormalities in common variable immunodeficiency.

作者信息

Jaffe J S, Eisenstein E, Sneller M C, Strober W

机构信息

Mucosal Immunity Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.

出版信息

Pediatr Res. 1993 Jan;33(1 Suppl):S24-7; discussion S27-8. doi: 10.1203/00006450-199305001-00128.

Abstract

Common variable immunodeficiency (CVI) is a heterogeneous condition marked by a number of different immunologic defects. One group of patients, perhaps 60% of the CVI group as a whole, is characterized by T cells that produce reduced amounts of IL-2 (mRNA and protein product), IL-4, and IL-5 (mRNA) when stimulated with phytohemagglutinin. This defect does not extend to all lymphokines, however, because the cells produce normal amounts of interferon-gamma (mRNA and protein product) when exogenous IL-2 is present. Recently, we have reexamined the T cell lymphokine production defect using a panoply of T-cell activation stimuli and have shown that the defect is a subtle one that depends on activation of the cell via the CD3-T-cell receptor complex. Because T cells proliferate normally when stimulated via this receptor, this finding suggests the presence of a "downstream" defect, perhaps one involving the factors that are necessary for activation of lymphokine genes. A second form of CVI, in this case involving approximately 30% of the CVI group as a whole, is characterized by a reduced CD4/CD8 ratio and elevated numbers of CD8+ T cells bearing the CD57 marker. Although the CD4+ T cells in this patient group elaborate normal amounts of IL-2 under various activation conditions, their CD8+ T cells produce increased amounts of interferon-gamma. Furthermore, the CD8+ T cells in this case act as "suppressor" T cells, which suppress IgG production but not IgM production of purified (normal) SAC+, IL-2-induced B cells.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

普通可变免疫缺陷(CVI)是一种具有多种不同免疫缺陷特征的异质性疾病。在整个CVI患者群体中,约60%的患者属于一组,其特征为T细胞在用植物血凝素刺激时,产生的白细胞介素-2(mRNA和蛋白质产物)、白细胞介素-4和白细胞介素-5(mRNA)数量减少。然而,这种缺陷并不扩展到所有淋巴因子,因为当存在外源性白细胞介素-2时,这些细胞产生正常量的干扰素-γ(mRNA和蛋白质产物)。最近,我们使用一系列T细胞激活刺激重新检查了T细胞淋巴因子产生缺陷,并表明该缺陷很细微,取决于通过CD3-T细胞受体复合物对细胞的激活。由于T细胞通过该受体刺激时正常增殖,这一发现提示存在“下游”缺陷,可能涉及激活淋巴因子基因所需的因子。CVI的第二种形式,在整个CVI群体中约占30%,其特征为CD4/CD8比值降低以及携带CD57标记的CD8+T细胞数量增加。尽管该患者组中的CD4+T细胞在各种激活条件下产生正常量的白细胞介素-2,但其CD8+T细胞产生的干扰素-γ量增加。此外,在这种情况下,CD8+T细胞作为“抑制性”T细胞,抑制纯化的(正常的)SAC+、白细胞介素-2诱导的B细胞产生IgG,但不抑制其产生IgM。(摘要截短于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验